Literature DB >> 16631737

Immune modulation by mesenchymal stem cells.

Ida Rasmusson1.   

Abstract

Mesenchymal stem cells (MSCs) have been shown to suppress activation of T cells both in vivo and in vitro. In vivo, this may be a way for the body to maintain homeostasis and inhibit immune activation in distinct compartments, such as the bone marrow and the interface between mother and fetus. MSCs modulate the immune function of the major cell populations involved in alloantigen recognition and elimination, including antigen presenting cells, T cells, and natural killer cells. The molecular mechanism that mediates the immunosuppressive effect of MSCs is not completely understood.

Mesh:

Year:  2006        PMID: 16631737     DOI: 10.1016/j.yexcr.2006.03.019

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  108 in total

Review 1.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

2.  Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.

Authors:  Najib El Haddad; Dean Heathcote; Robert Moore; Sunmi Yang; Jamil Azzi; Bechara Mfarrej; Mark Atkinson; Mohamed H Sayegh; Jeng-Shin Lee; Philip G Ashton-Rickardt; Reza Abdi
Journal:  Blood       Date:  2010-11-12       Impact factor: 22.113

3.  The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells.

Authors:  Guangwu Xu; Yingyu Zhang; Liying Zhang; Guangwen Ren; Yufang Shi
Journal:  Biochem Biophys Res Commun       Date:  2007-07-20       Impact factor: 3.575

Review 4.  Immune regulation by non-lymphoid cells in transplantation.

Authors:  A-S Dugast; B Vanhove
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

Review 5.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

6.  Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression.

Authors:  Zyrafete Kuçi; Julia Seiberth; Hatixhe Latifi-Pupovci; Sibylle Wehner; Stefan Stein; Manuel Grez; Halvard Bönig; Ulrike Köhl; Thomas Klingebiel; Peter Bader; Selim Kuçi
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

7.  Transplanted xenogenic bone marrow stem cells survive and generate new bone formation in the posterolateral lumbar spine of non-immunosuppressed rabbits.

Authors:  Hyung-Jun Kim; Jong-Beom Park; Jin Kyung Lee; Eun-Young Park; Eun-Ae Park; K Daniel Riew; Seung-Koo Rhee
Journal:  Eur Spine J       Date:  2008-09-25       Impact factor: 3.134

Review 8.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

Review 9.  Tolerance in the Age of Immunotherapy.

Authors:  Jeffrey A Bluestone; Mark Anderson
Journal:  N Engl J Med       Date:  2020-09-17       Impact factor: 91.245

10.  Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10.

Authors:  Angela Dittmer; Kristina Hohlfeld; Jana Lützkendorf; Lutz P Müller; Jürgen Dittmer
Journal:  Cell Mol Life Sci       Date:  2009-07-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.